Is there a generic for Cidofovir?

Yes. The FDA Orange Book lists 2 approved generic (ANDA) applications for Cidofovir, referencing the brand VISTIDE. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Cidofovir?

VISTIDE (NDA 020638, GILEAD SCIENCES INC) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Cidofovir are approved?

Cidofovir is approved in the following dosage form: solution.

FDA Orange Book · active-ingredient family

Cidofovir

Cidofovir is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:VISTIDE · NDA 020638

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · solution

Product	Applicant	Application	TE	Approved
VISTIDERLD	GILEAD SCIENCES INC	NDA 020638	—	Jun 26, 1996

Generic (ANDA) products (2)

Product	Applicant	Application	TE	Approved
CIDOFOVIR	AVET LIFESCIENCES	ANDA 202501	AP	Jul 26, 2012
CIDOFOVIR	MYLAN INSTITUTIONAL	ANDA 201276	AP	Jun 27, 2012

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Cidofovir — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo